Instinct Brothers Co., Ltd Joins Forces with Relativity for a Public Offering
Instinct Brothers Co., Ltd has recently made a significant leap by entering into a definitive business combination agreement with Relativity Acquisition Corp. This merger marks an exciting juncture for both companies as they combine resources and expertise to enhance their market presence.
An Impressive Valuation for the New Entity
The planned merged entity will operate as Instinct Bio Technical Company Inc., with an impressive pro forma enterprise value estimated at about $242 million. This value is calculated under the assumption that there are no additional redemptions by Relativity’s public stockholders before the merger closes. This strategic move is expected to bring significant growth opportunities for the newly formed company.
Innovative Ventures in Regenerative Medicine
Instinct Brothers is a trailblazer in the field of regenerative medicine and stem cell technology, driven by a mission to leverage the potential of stem cell science. The company has developed a comprehensive ecosystem that spans stem-cell-based cosmeceuticals, research, and clinical applications. This robust platform reflects their commitment to integrating various elements of the industry—from university collaborations to direct-to-consumer retail.
A Vision for Skincare and Health
Utilizing a high-quality stem cell culture medium boasting over 380 cytokines and growth factors, Instinct Brothers is positioned at the forefront of stem cell-derived skincare. Their franchise GENREVER Clinic serves as a structured model aimed at delivering regenerative therapies across a variety of health challenges, including anti-aging and immune support. This strategic model not only enhances patient outcomes but also paves the way for innovative regenerative treatments.
Quality Production at ARTISANS PRODUCTION CO., LTD
In addition to its innovative therapies, Instinct Brothers operates ARTISANS PRODUCTION CO., LTD, an ISO 9001-certified manufacturing facility dedicated to crafting high-quality cosmeceuticals and medical-grade products. This facility plays a crucial role in ensuring precision manufacturing and stringent quality control, integral to the company’s commitment to excellence in regenerative medicine.
Leadership Committed to Growth
The management team, spearheaded by Tomoki Nagano, the founder and CEO of Instinct Brothers, is set to guide the Combined Company towards impactful global expansion. Nagano emphasizes that this merger is a transformational milestone aimed at enhancing access to advanced stem cell therapies worldwide. With plans to extend clinic models into new territories and bolster their operations, the company is well-positioned for future growth.
Insights from Industry Leaders
Tarek Tabsh, CEO of Relativity Acquisition Corp, expressed confidence in the prospects of Instinct Brothers, highlighting the unique properties of perinatal stem cells and their promising application potential in regenerative medicine. This collaboration not only reinforces the integrated business model that Instinct Brothers has established but also aligns with their mission to innovate and deliver next-generation healthcare solutions.
The Merger Details and What's Next
As outlined in the Merger Agreement, Relativity will fully acquire Instinct Brothers, transforming it into a publicly traded entity. The Combined Company is expected to emerge under the name Instinct Bio Technical Company Inc. and aims to initiate trading on the NASDAQ under the ticker symbol ‘BIOT’. The merger is anticipated to finalize in the third quarter of the upcoming year, contingent upon stockholder approvals and standard closing conditions.
Expert Advisors on Board
The success of this merger is supported by experienced advisors. Chardan Capital Markets LLC serves as the exclusive M&A and Capital Markets advisor for Instinct Brothers, while Darryl, Edward & Co. provides legal counsel. On the other side, Loeb & Loeb LLP and Barnett & Linn LLP act as legal advisors to Relativity Acquisition Corp.
About Instinct Brothers and Relativity Acquisition Corp.
Instinct Brothers is a Japanese company renowned for its integrated approach to stem cell technology and regenerative medicine, focusing on research, development, and clinical applications. Established with the vision of enhancing patient health through innovation, it aims to remain a leader in regenerative therapies. Meanwhile, Relativity Acquisition Corp. functions as a blank check company formed to identify and merge with promising businesses, facilitating growth and expansion opportunities in various sectors.
Frequently Asked Questions
What is the purpose of the merger between Instinct Brothers and Relativity Acquisition Corp?
The merger aims to enable Instinct Brothers to become a publicly traded entity, enhancing its market presence and allowing for further growth and innovation in regenerative medicine.
What new name will the merged company adopt?
The combined entity will be named Instinct Bio Technical Company Inc. following the completion of the merger.
When is the merger scheduled to close?
The merger is expected to close in the third quarter of the upcoming year, subject to regulatory approvals and customary closing conditions.
What sectors does Instinct Brothers operate in?
Instinct Brothers specializes in regenerative medicine and stem cell technology, encompassing research, manufacturing, and clinical applications, with a strong focus on cosmetic and healthcare solutions.
How is the quality of production ensured at Instinct Brothers?
Instinct Brothers operates an ISO 9001-certified manufacturing facility to ensure precision, quality control, and continuous innovation in their products.
